Erratum: Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice (Brain (2012) 135 (3551-3566) DOI:10.1093/brain/aws299);Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice

Brain

Volumn 135, Issue 12, 2012, Pages 3551-3566

  Patzkó, Ágnes ^a   Bai, Yunhong ^a,b   Saporta, Mario A ^a   Katona, István ^a   Wu, Xingyao ^a,b   Vizzuso, Domenica ^c,d   Feltri, M Laura ^c,d   Wang, Suola ^a,b   Dillon, Lisa M ^a   Kamholz, John ^a   Kirschner, Daniel ^e   Sarkar, Fazlul H ^a   Wrabetz, Lawrence ^c,d   Shy, Michael E ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e BOSTON COLLEGE   (United States)

Author keywords

Charcot Marie Tooth disease 1B; curcumin; myelin protein zero; peripheral neuropathy; unfolded protein response

Indexed keywords

CURCUMIN; CURCUMIN DERIVATIVE; CYCLIC AMP; MYELIN; PHOSPHATIDYLCHOLINE; PROTEIN C JUN; SESAME SEED OIL; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; MOUSE; MUSCLE ACTION POTENTIAL; MYELINATION; NERVE CONDUCTION; NERVE FIBER; NEUROMUSCULAR SYNAPSE; NEUROPATHY; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROTAROD TEST; SCHWANN CELL; SCIATIC NERVE; STOMACH LAVAGE;

EID: 84871760898     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu269     Document Type: Erratum

References (46)

1. Abidi AL. Chromatographic analysis of plant sterols in foods and vegetable oils. J Chromatogr A 2001; 935: 173-201.
2. Agrawal DK, Mishra PK. Curcumin and its analogues: potential antic-ancer agents. Med Res Rev 2009; 30: 818-60.
3. Agrawal D, Hawk R, Avila RL, Inouye H, Kirschner DA. Internodal mye-lination during development quantitated using X-ray diffraction. J Struct Biol 2009; 168: 521-6.
4. Back SH, Lee K, Vink E, Kaufman RJ. Cytoplasmic IRE1alpha-mediated XBP1 mRNA splicing in the absence of nuclear processing and endo-plasmic reticulum stress. J Biol Chem 2006; 281: 18691-706.
5. Bai Y, Ianokova E, Pu Q, Ghandour K, Levinson R, Martin JJ, et al. Effect of an R69C mutation in the myelin protein zero gene on myelination and ion channel subtypes. Arch Neurol 2006; 63: 1787-94.
6. Blanchard AD, Sinanan A, Parmantier E, Zwart R, Broos L, Meijer D, et al. Oct-6 (SCIP/Tst-1) is expressed in Schwann cell precursors, embryonic Schwann cells, and postnatal myelinating Schwann cells: comparison with Oct-1, Krox-20, and Pax-3. J Neurosci Res 1996; 46: 630-40.
7. Brill MS, Lichtman JW, Thompson W, Zuo Y, Misgeld T. Spatial constraints dictate glial territories at murine neuromuscular junctions. J Cell Biol 2011; 195: 293-305.
8. Butowt R, von Bartheld CS. Fates of neurotrophins after retrograde axonal transport: phosphorylation of p75NTR is a sorting signal for delayed degradation. J Neurosci 2009; 29: 10715-29.
9. Corson TW, Crews CM. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell 2007; 130: 769-74.
10. Court FA, Brophy PJ, Ribchester RR. Remodeling of motor nerve terminals in demyelinating axons of periaxin-null mice. Glia 2008; 56: 471-9.
11. Egan ME, Glockner-Pagel J, Ambrose C, Cahill PA, Pappoe L, Balamuth N, et al. Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat Med 2002; 8: 485-92.
12. Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glockner-Pagel J, et al. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 2004; 304: 600-2.
13. Epstein J, Sanderson IR, Macdonald TT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr 2010; 103: 1545-57.
14. Grandis M, Vigo T, Passalacqua M, Jain M, Scazzola S, La Padula V, et al. Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations. Hum Mol Genet 2008; 17: 1877-89.
15. Hutton EJ, Carty L, Laura M, Houlden H, Lunn MP, Brandner S, et al. c-Jun expression in human neuropathies: a pilot study. Journal of the peripheral nervous system. J Peripher Nerv Syst 2011; 16: 295-303.
16. Inoue K, Osaka H, Sugiyama N, Kawanishi C, Onishi H, Nezu A, et al. A duplicated PLP gene causing Pelizaeus-Merzbacher disease detected by comparative multiplex PCR. Am J Hum Genet 1996; 59: 32-9.
17. Jauhiainen A, Thomsen C, Strombom L, Grundevik P, Andersson C, Danielsson A, et al. Distinct cytoplasmic and nuclear functions of the stress induced protein DDIT3/CHOP/GADD153. PloS One 2012; 7: e33208.
18. Jessen KR, Mirsky R. The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci 2005; 6: 671-82.
19. Khajavi M, Inoue K, Wiszniewski W, Ohyama T, Snipes GJ, Lupski Jr. Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants. Am J Hum Genet 2005; 77: 841-50.
20. Khajavi M, Shiga K, Wiszniewski W, He F, Shaw CA, Yan J, et al. Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy. Am J Hum Genet 2007; 81: 438-53.
21. Kimura J. Nerve conduction and electromyography. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Philadelphia, PA: Elsevier/Saunders; 2005. p. 899-970.
22. Limpert AS, Carter BD. Axonal neuregulin 1 type III activates NF-kappaB in Schwann cells during myelin formation. J Biol Chem 2010; 285: 16614-622.
23. Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, Gescher AJ. Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol 2007; 60: 171-7.
24. Miller LJ, Patzko A, Lewis RA, Shy ME. Phenotypic presentation of the Ser63Del MPZ mutation. Journal of the peripheral nervous system. J Peripher Nerv Syst 2012; 17: 197-200.
25. Nelis E, Van Broeckhoven C, De Jonghe P, Lofgren A, Vandenberghe A, Latour P, et al. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet 1996; 4: 25-33.
26. Nickols JC, Valentine W, Kanwal S, Carter BD. Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation. Nat Neurosci 2003; 6: 161-7.
27. Padhye S, Banerjee S, Chavan D, Pandye S, Swamy KV, Ali S, et al. Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice. Pharm Res 2009; 26: 2438-45.
28. Parkinson DB, Bhaskaran A, Arthur-Farraj P, Noon LA, Woodhoo A, Lloyd AC, et al. c-Jun is a negative regulator of myelination. J Cell Biol 2008; 181: 625-37.
29. Pennuto M, Tinelli E, Malaguti M, Del Carro U, D'Antonio M, Ron D, et al. Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in charcot-marie-tooth 1B mice. Neuron 2008; 57: 393-405.
30. Ryu EJ, Wang JY, Le N, Baloh RH, Gustin JA, Schmidt RE, et al. Misexpression of Pou3f1 results in peripheral nerve hypomyelination and axonal loss. J Neurosci 2007; 27: 11552-9.
31. Saher G, Quintes S, Mobius W, Wehr MC, Kramer-Albers EM, Brugger B, et al. Cholesterol regulates the endoplasmic reticulum exit of the major membrane protein P0 required for peripheral myelin compaction. J Neurosci 2009; 29: 6094-104.
32. Saher G, Rudolphi F, Corthals K, Ruhwedel T, Schmidt KF, Lowel S, et al. Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet. Nat Med 2012; 18: 1130-5.
33. Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME. Charcot marie tooth (CMT) subtypes and genetic testing strategies. Ann Neurol 2011; 69: 22-33.
34. Saporta MA, Katona I, Lewis RA, Masse S, Shy ME, Li J. Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A. Brain 2009; 132: 3263-73.
35. Saporta MA, Shy BR, Patzko A, Bai Y, Pennuto M, Ferri C, et al. MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B. Brain 2012; 135: 2032-47.
36. Shapiro L, Doyle JP, Hensley P, Colman DR, Hendrickson WA. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 1996; 17: 435-49.
37. Shy ME, Jani A, Krajewski KM, Lewis RA, Li J, Shy RR, et al. Phenotypic clustering in MPZ mutations. Brain 2004; 127: 371-84.
38. Singh S. Indian pharma enters the global arena. Cell 2007; 128: 811-14.
39. Svaren J, Meijer D. The molecular machinery of myelin gene transcription in Schwann cells. Glia 2008; 56: 1541-51.
40. Trapp BD, Pfeiffer SE, Anitei A, Kidd GJ. Cell biology and myelin assembly. In: Lazzarini RA, editor. Myelin biology and disorders. San Diego/London: Elsevier Academic Press; 2003. p. 29-56.
41. Warner LE, Hilz MJ, Appel SH, Killian JM, Kolodry EH, Karpati G, et al. Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypo-myelination. Neuron 1996; 17: 451-60.
42. Wrabetz L, D'Antonio M, Pennuto M, Dati G, Tinelli E, Fratta P, et al. Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice. J Neurosci 2006; 26: 2358-68.
43. Yin X, Kidd GJ, Pioro EP, McDonough J, Dutta R, Feltri ML, et al. Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals. J Neurosci 2004; 24: 3890-8.
44. Yoon C, Korade Z, Carter BD. Protein kinase A-induced phosphorylation of the p65 subunit of nuclear factor-kappaB promotes Schwann cell differentiation into a myelinating phenotype. J Neurosci 2008; 28: 3738-46.
45. Yoshida H, Haze K, Yanagi H, Yura T, Mori K. Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors. J Biol Chem 1998; 273: 33741-9.
46. Zorick TS, Syroid DE, Arroyo E, Scherer SS, Lemke G. The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol Cell Neurosci 1996; 8: 129-45.